Literature DB >> 28602422

Loss-of-Function Variants in MYLK Cause Recessive Megacystis Microcolon Intestinal Hypoperistalsis Syndrome.

Danny Halim1, Erwin Brosens1, Françoise Muller2, Michael F Wangler3, Arthur L Beaudet3, James R Lupski4, Zeynep H Coban Akdemir5, Michael Doukas6, Hans J Stoop6, Bianca M de Graaf1, Rutger W W Brouwer7, Wilfred F J van Ijcken7, Jean-François Oury8, Jonathan Rosenblatt8, Alan J Burns9, Dick Tibboel10, Robert M W Hofstra11, Maria M Alves12.   

Abstract

Megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS) is a congenital disorder characterized by loss of smooth muscle contraction in the bladder and intestine. To date, three genes are known to be involved in MMIHS pathogenesis: ACTG2, MYH11, and LMOD1. However, for approximately 10% of affected individuals, the genetic cause of the disease is unknown, suggesting that other loci are most likely involved. Here, we report on three MMIHS-affected subjects from two consanguineous families with no variants in the known MMIHS-associated genes. By performing homozygosity mapping and whole-exome sequencing, we found homozygous variants in myosin light chain kinase (MYLK) in both families. We identified a 7 bp duplication (c.3838_3844dupGAAAGCG [p.Glu1282_Glyfs∗51]) in one family and a putative splice-site variant (c.3985+5C>A) in the other. Expression studies and splicing assays indicated that both variants affect normal MYLK expression. Because MYLK encodes an important kinase required for myosin activation and subsequent interaction with actin filaments, it is likely that in its absence, contraction of smooth muscle cells is impaired. The existence of a conditional-Mylk-knockout mouse model with severe gut dysmotility and abnormal function of the bladder supports the involvement of this gene in MMIHS pathogenesis. In aggregate, our findings implicate MYLK as a gene involved in the recessive form of MMIHS, confirming that this disease of the visceral organs is heterogeneous with a myopathic origin.
Copyright © 2017 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MMIHS; MYLK; bladder and intestinal obstruction; smooth muscle contractility

Mesh:

Substances:

Year:  2017        PMID: 28602422      PMCID: PMC5501771          DOI: 10.1016/j.ajhg.2017.05.011

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

Review 1.  Dedicated myosin light chain kinases with diverse cellular functions.

Authors:  K E Kamm; J T Stull
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

2.  Myosin light chain kinase knockout.

Authors:  A V Somlyo; H Wang; N Choudhury; A S Khromov; M Majesky; G K Owens; A P Somlyo
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

3.  Consanguineous marriages : Preconception consultation in primary health care settings.

Authors:  Hanan Hamamy
Journal:  J Community Genet       Date:  2011-11-22

4.  Megacystis-microcolon-intestinal hypoperistalsis syndrome: a new cause of intestinal obstruction in the newborn. Report of radiologic findings in five newborn girls.

Authors:  W E Berdon; D H Baker; W A Blanc; B Gay; T V Santulli; C Donovan
Journal:  AJR Am J Roentgenol       Date:  1976-05       Impact factor: 3.959

5.  CLMP is required for intestinal development, and loss-of-function mutations cause congenital short-bowel syndrome.

Authors:  Christine S Van Der Werf; Tara D Wabbersen; Nai-Hua Hsiao; Joana Paredes; Heather C Etchevers; Peter M Kroisel; Dick Tibboel; Candice Babarit; Richard A Schreiber; Edward J Hoffenberg; Michel Vekemans; Sirkka L Zeder; Isabella Ceccherini; Stanislas Lyonnet; Ana S Ribeiro; Raquel Seruca; Gerard J Te Meerman; Sven C D van Ijzendoorn; Iain T Shepherd; Joke B G M Verheij; Robert M W Hofstra
Journal:  Gastroenterology       Date:  2011-12-07       Impact factor: 22.682

6.  The Genotype-Tissue Expression (GTEx) project.

Authors: 
Journal:  Nat Genet       Date:  2013-06       Impact factor: 38.330

7.  A homozygous loss-of-function variant in MYH11 in a case with megacystis-microcolon-intestinal hypoperistalsis syndrome.

Authors:  Julie Gauthier; Bouchra Ouled Amar Bencheikh; Fadi F Hamdan; Steven M Harrison; Linda A Baker; Françoise Couture; Isabelle Thiffault; Reda Ouazzani; Mark E Samuels; Grant A Mitchell; Guy A Rouleau; Jacques L Michaud; Jean-François Soucy
Journal:  Eur J Hum Genet       Date:  2014-11-19       Impact factor: 4.246

8.  Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome.

Authors:  Michael F Wangler; Claudia Gonzaga-Jauregui; Tomasz Gambin; Samantha Penney; Timothy Moss; Atul Chopra; Frank J Probst; Fan Xia; Yaping Yang; Steven Werlin; Ieva Eglite; Liene Kornejeva; Carlos A Bacino; Dustin Baldridge; Jeff Neul; Efrat Lev Lehman; Austin Larson; Joke Beuten; Donna M Muzny; Shalini Jhangiani; Richard A Gibbs; James R Lupski; Arthur Beaudet
Journal:  PLoS Genet       Date:  2014-03-27       Impact factor: 5.917

9.  ACTG2 variants impair actin polymerization in sporadic Megacystis Microcolon Intestinal Hypoperistalsis Syndrome.

Authors:  Danny Halim; Robert M W Hofstra; Luca Signorile; Rob M Verdijk; Christine S van der Werf; Yunia Sribudiani; Rutger W W Brouwer; Wilfred F J van IJcken; Niklas Dahl; Joke B G M Verheij; Clarisse Baumann; John Kerner; Yolande van Bever; Niels Galjart; Rene M H Wijnen; Dick Tibboel; Alan J Burns; Françoise Muller; Alice S Brooks; Maria M Alves
Journal:  Hum Mol Genet       Date:  2015-12-08       Impact factor: 6.150

10.  Genic insights from integrated human proteomics in GeneCards.

Authors:  Simon Fishilevich; Shahar Zimmerman; Asher Kohn; Tsippi Iny Stein; Tsviya Olender; Eugene Kolker; Marilyn Safran; Doron Lancet
Journal:  Database (Oxford)       Date:  2016-04-05       Impact factor: 3.451

View more
  16 in total

1.  CAKUT and Autonomic Dysfunction Caused by Acetylcholine Receptor Mutations.

Authors:  Nina Mann; Franziska Kause; Erik K Henze; Anant Gharpure; Shirlee Shril; Dervla M Connaughton; Makiko Nakayama; Verena Klämbt; Amar J Majmundar; Chen-Han W Wu; Caroline M Kolvenbach; Rufeng Dai; Jing Chen; Amelie T van der Ven; Hadas Ityel; Madeleine J Tooley; Jameela A Kari; Lucy Bownass; Sherif El Desoky; Elisa De Franco; Mohamed Shalaby; Velibor Tasic; Stuart B Bauer; Richard S Lee; Jonathan M Beckel; Weiqun Yu; Shrikant M Mane; Richard P Lifton; Heiko Reutter; Sian Ellard; Ryan E Hibbs; Toshimitsu Kawate; Friedhelm Hildebrandt
Journal:  Am J Hum Genet       Date:  2019-11-07       Impact factor: 11.025

Review 2.  Pediatric Intestinal Pseudo-obstruction in the Era of Genetic Sequencing.

Authors:  Heidi E Gamboa; Manu Sood
Journal:  Curr Gastroenterol Rep       Date:  2019-12-17

3.  Recurrent arginine substitutions in the ACTG2 gene are the primary driver of disease burden and severity in visceral myopathy.

Authors:  Nurit Assia Batzir; Pranjali Kishor Bhagwat; Austin Larson; Zeynep Coban Akdemir; Maciej Bagłaj; Leon Bofferding; Katherine B Bosanko; Skander Bouassida; Bert Callewaert; Ashley Cannon; Yazmin Enchautegui Colon; Adolfo D Garnica; Margaret H Harr; Sandra Heck; Anna C E Hurst; Shalini N Jhangiani; Bertrand Isidor; Rebecca O Littlejohn; Pengfei Liu; Pilar Magoulas; Helen Mar Fan; Ronit Marom; Scott McLean; Marjan M Nezarati; Kimberly M Nugent; Michael B Petersen; Maria L Rocha; Elizabeth Roeder; Robert Smigiel; Ian Tully; James Weisfeld-Adams; Katerina O Wells; Jennifer E Posey; James R Lupski; Arthur L Beaudet; Michael F Wangler
Journal:  Hum Mutat       Date:  2019-12-19       Impact factor: 4.878

Review 4.  Smooth muscle motility disorder phenotypes: A systematic review of cases associated with seven pathogenic genes (ACTG2, MYH11, FLNA, MYLK, RAD21, MYL9 and LMOD1).

Authors:  Ninon Fournier; Alexandre Fabre
Journal:  Intractable Rare Dis Res       Date:  2022-08

5.  Expanding ACTA2 genotypes with corresponding phenotypes overlapping with smooth muscle dysfunction syndrome.

Authors:  Anita Kaw; Kaveeta Kaw; Ellen M Hostetler; Ana Beleza-Meireles; Adam Smith-Collins; Catherine Armstrong; Ingrid Scurr; Timothy Cotts; Rajani Aatre; Michael J Bamshad; Dawn Earl; Abraham Groner; Katherine Agre; Yehuda Raveh; Callie S Kwartler; Dianna M Milewicz
Journal:  Am J Med Genet A       Date:  2022-05-14       Impact factor: 2.578

6.  Copy number variations in a population with prune belly syndrome.

Authors:  Nida S Iqbal; Thomas A Jascur; Steven Harrison; Catherine Chen; Michelle K Arevalo; Daniel Wong; Emma Sanchez; Gwen Grimsby; Kathleen Wilson; Linda A Baker
Journal:  Am J Med Genet A       Date:  2018-10-04       Impact factor: 2.802

7.  Homozygous deletion in MYL9 expands the molecular basis of megacystis-microcolon-intestinal hypoperistalsis syndrome.

Authors:  Carolina Araujo Moreno; Nara Sobreira; Elizabeth Pugh; Peng Zhang; Gary Steel; Fábio Rossi Torres; Denise Pontes Cavalcanti
Journal:  Eur J Hum Genet       Date:  2018-02-16       Impact factor: 4.246

Review 8.  Visceral myopathy: clinical syndromes, genetics, pathophysiology, and fall of the cytoskeleton.

Authors:  Sohaib Khalid Hashmi; Rachel Helen Ceron; Robert O Heuckeroth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-03-17       Impact factor: 4.871

9.  Hypoxic modulation of fetal vascular MLCK abundance, localization, and function.

Authors:  Dane W Sorensen; Desirelys Carreon; James M Williams; William J Pearce
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-10-28       Impact factor: 3.619

10.  Fatal thoracic aortic aneurysm and dissection in a large family with a novel MYLK gene mutation: delineation of the clinical phenotype.

Authors:  Adel Shalata; Mohammad Mahroom; Dianna M Milewicz; Gong Limin; Fadi Kassum; Khader Badarna; Nader Tarabeih; Nimmer Assy; Rona Fell; Hector Cohen; Munir Nashashibi; Alejandro Livoff; Muhammad Azab; George Habib; Dan Geiger; Omer Weissbrod; William Nseir
Journal:  Orphanet J Rare Dis       Date:  2018-03-15       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.